Skip to main content
Premium Trial:

Request an Annual Quote

Genome BC Receives $800K from Canadian Government

NEW YORK (GenomeWeb News) – The Canadian government’s Western Economic Diversification division is making a four-year, CAN$800,000 ($805,000) investment in the province of British Columbia’s Genome BC. The funding is intended to support multi-stakeholder, Western Canadian genomics networks.
 
With the new funding, Genome BC expects to create its own set of genomics networks — encompassing industry, provincial governments, universities, federal laboratories, and other research agencies — and to participate in other Western Canadian genomics networks led by Genome Prairie and Genome Alberta.
 
These networks, which are expected to have implications for everything from human health to natural resources and the environment, are intended to promote collaboration, decrease research duplication, and help the genomics community secure investments from other partners.
 
“For the first time, genome organizations across the West will have a platform to collaborate with western companies and research organizations on market-driven research and the commercialization of new technologies,” Russ Hiebert, a Member of Parliament for South Surrey, BC, said in a statement.
 
Canada has six genomics and proteomics networks funded through the central organization Genome Canada.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more